Onconano Medicine
Southlake
About Onconano Medicine
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $188.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2021)
- Website: onconano.com
- Phone: [email protected]
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/onconano-medicine-43010 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.